---
title: "Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic"
nct_id: NCT01223872
overall_status: COMPLETED
sponsor: Vanderbilt University Medical Center
study_type: OBSERVATIONAL
primary_condition: Childhood Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01223872.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01223872"
ct_last_update_post_date: 2017-04-04
last_seen_at: "2026-05-12T06:26:34.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic

**Official Title:** Childhood Cancer Survivors' Knowledge of Their Diagnosis, Treatment, and Risk of Late Effects: The Impact of Care in a Specialized Survivorship Clinic

**NCT ID:** [NCT01223872](https://clinicaltrials.gov/study/NCT01223872)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 188
- **Lead Sponsor:** Vanderbilt University Medical Center
- **Conditions:** Childhood Cancer
- **Start Date:** 2010-08
- **Completion Date:** 2015-08
- **CT.gov Last Update:** 2017-04-04

## Brief Summary

This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.

## Eligibility

- **Maximum age:** 21 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Treatment for primary malignancy per risk-adapted protocol
* Age ≤ 21 years at time of diagnosis
* Currently alive without evidence of disease
* Off therapy for no more than 15 years

Exclusion Criteria:

-Patients who have received a bone marrow transplant
```

## Arms

- **Routine Patient Care**
- **Previously-enrolled REACH Clinic Patients**
- **New REACH Clinic Patients**

## Interventions

- **interview** (OTHER) — * Standard Interview (2-15 years from last treatment)
* Demographic data interview (pre-initial study interview)
- **clinic visit and interview** (OTHER) — * REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview (3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)
- **interviews and clinic visit** (OTHER) — * Pre-REACH Clinic Interview(2-15 yrs from last treatment)
* REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview(1mo from initial clinic visit)
* Post-REACH Clinic Interview(3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)

## Primary Outcomes

- **Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach.** _(time frame: 12 months)_ — In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.

## Secondary Outcomes

- **Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints.** _(time frame: pre-clinic and a post-clinic interviews at 1 and 3 months.)_
- **An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan.** _(time frame: 12 months)_
- **A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic** _(time frame: 12 months)_

## Locations (1)

- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.vanderbilt-ingram cancer center|nashville|tennessee|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01223872.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01223872*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*